about
mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomasInhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cellsVisualizing extravasation dynamics of metastatic tumor cellsMechanisms of tumor cell extravasation in an in vitro microvascular network platformKinesin-5 Contributes to Spindle-length Scaling in the Evolution of Cancer toward MetastasisConstruction of a metastasis-associated gene subtracted cDNA library of human colorectal carcinoma by suppression subtraction hybridization.Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials.Network signatures of nuclear and cytoplasmic density alterations in a model of pre and postmetastatic colorectal cancerMiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cellsmiR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis.Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneityThe involvement of miR-23a/APAF1 regulation axis in colorectal cancer.Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell linesSMK-17, a MEK1/2-specific inhibitor, selectively induces apoptosis in β-catenin-mutated tumorsLoss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancerVariants of the PPARD gene and their clinicopathological significance in colorectal cancer.An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agent.Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cellsImpact of Procyanidins from Different Berries on Caspase 8 Activation in Colon Cancer.Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites.H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.Silencing of Wnt5a during colon cancer metastasis involves histone modifications.EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer.O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome.Extracellular Hsp90 and TGFβ regulate adhesion, migration and anchorage independent growth in a paired colon cancer cell line model.A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cellsExtracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.Primary tumor- and metastasis-derived colon cancer cells differently modulate connexin expression and function in human capillary endothelial cells.Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cellsIRS2 is a candidate driver oncogene on 13q34 in colorectal cancer.Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival.Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology.Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migrationHepatic vitamin A preloading reduces colorectal cancer metastatic multiplicity in a mouse xenograft model.Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
P2860
Q27851707-133501F8-78C8-4464-9896-AE834D8DC6ACQ28484668-C8D5986B-AE59-45F2-96D7-D61867FFE73FQ28542858-A2B6949C-C26A-413E-A10D-A3823AE6D14EQ30494902-224BBEC1-80FB-4D73-A7F0-0F60FE00181FQ30579230-898F2B85-77F7-48A3-B643-F40E10B0D850Q30825161-160C0BAB-92C4-454D-8EA8-0B520A1A24FEQ31052792-4CB6F47B-7A5E-4BDF-B74A-5182B9148A47Q33299698-6EC5567F-A31F-4436-BF54-9C5722B20648Q33604064-2AA0A616-EB7F-45C8-B4F6-4BED265B4FBDQ33648460-45A2CE88-C87C-4CA3-9350-744686F31DBDQ33815943-8EE48230-2923-431F-B12D-49A6DEF98263Q33853447-4F9774F2-7097-4866-B342-E60F4C43978AQ33875354-F0220F12-6852-473F-A54A-31DBACA7D504Q34072278-E1E1AB63-A220-419A-ADDB-9282040AE3A7Q34544632-4086C803-0B8C-49BE-BD51-BA1BEA45840AQ35035656-D3C3722C-83AB-49B0-BB6D-6B43BC03557DQ35059908-D4865FC8-939C-4BA2-A737-E2DF5AB655E2Q35082686-70F1FA32-113F-4455-9E21-86D5CEDA8AE8Q35269036-4C768101-C10B-4688-82B0-07D2FF4FCAD8Q35497344-C6ACB55C-4463-4B7E-9526-801CB4CB4B23Q35769006-4C104461-6472-4F13-B964-943F972B8F4EQ35781371-61AFE028-AEE1-452D-BD28-AF622B4CD3A2Q35931441-2AE3E76F-4CFD-4DF0-811D-EF034945337EQ36100968-FA6DF669-2422-4D68-9F96-315D6DFA3091Q36155201-31CB2206-9337-42A6-951F-1F2DD22F49AAQ36156032-76E8DBF2-0FE5-422B-8631-FF94EE6AEA9FQ36217277-F45E05BE-3533-4861-AA99-DD832F0BB179Q36311193-AC9EF5C2-D886-46D7-A47E-C7FF1376C777Q36357411-A52D5C97-03EC-493B-9986-9E1C56980B16Q36411158-E6CF793C-1355-4AB6-A98C-AB50068B1590Q36557140-71DF50B6-966D-4571-A01E-AAC5312F603AQ36559874-0C523EE2-1E4B-4EA1-ABE8-C38BF3B836AEQ36879136-9F729209-64E5-4049-8191-DABCCCD91E02Q36962652-6830267A-64DA-49BB-988E-C600D906CD29Q36983432-A0B839CC-5228-43ED-BE19-F0BE1A9B5773Q36996297-D2B7ABAB-076D-41B8-AB02-FFAEF71DA5A7Q37017273-C797A4C2-B579-406C-A210-CE9DA4161ACDQ37113219-02B0BD71-9C94-4207-82CA-D67C4ADC780FQ37313157-44F56F87-A93D-494A-B626-DE1AB7DAAC0AQ37327751-5D27DED4-0248-40D5-94FF-A95AF2C340B7
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Validation of a model of colon cancer progression.
@en
Validation of a model of colon cancer progression.
@nl
type
label
Validation of a model of colon cancer progression.
@en
Validation of a model of colon cancer progression.
@nl
prefLabel
Validation of a model of colon cancer progression.
@en
Validation of a model of colon cancer progression.
@nl
P2093
P1476
Validation of a model of colon cancer progression.
@en
P2093
P2860
P304
P356
10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K
P577
2000-12-01T00:00:00Z